Department of Physiology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
Clinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon.
Pan Afr Med J. 2020 Oct 5;37:122. doi: 10.11604/pamj.2020.37.122.21156. eCollection 2020.
several international guidelines are available on drug treatment for hypertension, but the control of hypertension remains very poor in sub-Saharan Africa (SSA). We investigated the commonly prescribed antihypertensive drugs and their association with blood pressure (BP) control in adult Cameroonians.
we consecutively recruited hypertensive outpatients attending the Buea and Limbe Regional Hospitals (southwest region of Cameroon). Controlled BP was defined as BP < 140/90mmHg in hypertensive patients aged 60 years or younger, diabetics or patients with chronic kidney disease or a BP < 150/90mmHg in non-diabetic hypertensive patients older than 60 years of age (JNC8).
of the 408 participants included (mean age 61.1 years), 67% were female. The median duration of hypertension was 6 years and the median duration of the current treatment was 22 weeks. Commonly prescribed antihypertensives were calcium channel blockers (CCB, 35.1%), thiazide/thiazide-like diuretics (TD/TLD, 26.1%) and angiotensin-converting enzyme inhibitors (ACEI, 19.5%). The median monthly cost of antihypertensive was 10279.6 CFA (approximately equal to US$ 172). Seventy percent (70%) of participants were receiving at least 2 drugs, with ACEI+TD/TLD, CCB+TD/TLD, and ACEI+CCB+TD/TLD being the most frequent combination. The rate of BP control was 52% overall, and 60% in participants on monotherapy.
CCBs were the most prescribed single antihypertensive drugs in this setting while ACEI+TD/TLD was the most common combination. About half of patients were at target BP control levels Improving availability and affordability of these medications may improve hypertension management and control.
有几项关于高血压药物治疗的国际指南,但在撒哈拉以南非洲(SSA),高血压的控制仍然非常差。我们研究了在喀麦隆成年人中常用的降压药物及其与血压(BP)控制的关系。
我们连续招募了在 Buea 和 Limbe 地区医院(喀麦隆西南部地区)就诊的高血压门诊患者。在年龄 60 岁或以下的高血压患者、糖尿病患者或慢性肾脏病患者中,控制血压定义为血压<140/90mmHg;在年龄超过 60 岁的非糖尿病高血压患者中,控制血压定义为血压<150/90mmHg(JNC8)。
408 名参与者中(平均年龄 61.1 岁),67%为女性。高血压的中位病程为 6 年,目前治疗的中位时间为 22 周。常用的降压药物有钙通道阻滞剂(CCB,35.1%)、噻嗪/噻嗪样利尿剂(TD/TLD,26.1%)和血管紧张素转换酶抑制剂(ACEI,19.5%)。降压药的月平均费用为 10279.6 非洲法郎(约合 172 美元)。70%的参与者至少服用 2 种药物,ACEI+TD/TLD、CCB+TD/TLD 和 ACEI+CCB+TD/TLD 是最常见的组合。总的降压率为 52%,单药治疗的降压率为 60%。
在这种情况下,CCB 是最常用的单一降压药物,而 ACEI+TD/TLD 是最常见的组合。大约一半的患者血压控制在目标水平,改善这些药物的可及性和可负担性可能会改善高血压的管理和控制。